(Q44393961)

2 December 2017

0 references

Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes (English)

1 reference

2 December 2017

0 references

1 reference

1 reference

1 reference

1 reference

1 reference

Jones TA

1

1 reference

2 December 2017

Sautter M

series ordinal

2

1 reference

2 December 2017

Van Gaal LF

series ordinal

3

1 reference

2 December 2017

Jones NP

series ordinal

4

1 reference

2 December 2017

publication date

1 May 2003

1 reference

Diabetes, Obesity and Metabolism

2 December 2017

published in

1 reference

2 December 2017

volume

5

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

163-170

1 reference

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00258.X

Insulin resistance and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00258.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00258.X

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00258.X

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00258.X

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00258.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00258.X

Insulin resistance: an independent risk factor for cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00258.X

10.1046/J.1463-1326.2003.00258.X

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference